Advertisement

Reactions Weekly

, Volume 1747, Issue 1, pp 162–162 | Cite as

Ipilimumab/nivolumab/pembrolizumab

Various toxicities: 17 case reports
Case report
  • 39 Downloads

Reference

  1. Richter MD, et al. Rheumatic Syndromes Associated With Immune Checkpoint Inhibitors: A Single-Center Cohort of Sixty-One Patients. Arthritis and Rheumatology 71: 468-475, No. 3, Mar 2019. Available from: URL: http://doi.org/10.1002/art.40745 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations